Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke "A2NTX"

Active, not recruiting

Phase 2/3 Results N/A

Eligibility Criteria

Inclusion Criteria

- patients with lower limb spasticity after stroke
- duration more than 6 months
- Modified Ashworth Scale of ankle joint more than 2

Exclusion Criteria

- patients with previous botulinum toxin injections to lower limbs
- patients with serious hepatic, renal or cardiac dysfunction
- patients with respiratory failure
- patients who cannot understand the instructions